Sources
 | This business-related Belgian biographical article is a stub. You can help Wikipedia by expanding it. |
Staf Van Reet is a Belgian scientist and businessman. Currently he is Managing Director of the biotech company Viziphar Biosciences BVBA, and member of the Board of Directors of Janssen Pharmaceutica and the VIB. He was succeeded as Chairman of FlandersBio by Johan Cardoen.
He obtained a degree of engineering in applied biological sciences and a PhD in agricultural sciences from the Katholieke Universiteit Leuven (Leuven, Belgium) and a law degree from the University of Antwerp (Antwerp, Belgium).
In 1972, he started his career at Janssen Pharmaceutica, as a scientist in the Department of Theoretical Medicinal Chemistry. After a year he moved to the Department of Patents and Pharmacochemical Data Processing of Janssen Pharmaceutica, and he headed the department from 1977 until 1989. Since 1987 continued his career as General Manager of Janssen Biotech, Chairman of the Management Board of the Janssen Research Foundation (JRF) and from 1991 until 1999 as President of the Janssen Research Foundation and Managing Director of Janssen Pharmaceutica N.V. Until he retired, he was responsible for corporate venturing activities in Europe for Johnson & Johnson. In 2007 he founded Movetis together with Remi Van den Broeck, Dirk Reyn and Jan Schuurkes.
| | This business-related Belgian biographical article is a stub. You can help Wikipedia by expanding it. |
Vosselaar is a municipality located in the Belgian province of Antwerp. The municipality only comprises the town of Vosselaar proper. On January 1, 2006, Vosselaar had a total population of 10,142. The total area is 11.85 km² which gives a population density of 856 inhabitants per km².
The University of Antwerp is a major Belgian university located in the city of Antwerp. The official abbreviation is UA, but UAntwerpen is more recently used. The University of Antwerp has about 20,000 students, which makes it the third largest university in Flanders. The University of Antwerp is characterised by its high standards in education, internationally competitive research and entrepreneurial approach. It was founded in 2003 after the merger of three smaller universities.
Paul Adriaan Jan, Baron Janssen was a Belgian physician. He was the founder of Janssen Pharmaceutica, a pharmaceutical company with over 20,000 employees which is now a subsidiary of Johnson & Johnson.
Janssen Pharmaceuticals is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
VIB is a research institute located in Flanders, Belgium. It was founded by the Flemish government in 1995, and became a full-fledged institute on 1 January 1996. The main objective of VIB is to strengthen the excellence of Flemish life sciences research and to turn the results into new economic growth. VIB spends almost 80% of its budget on research activities, while almost 12% is spent on technology transfer activities and stimulating the creation of new businesses, in addition VIB spends approximately 2% on socio-economic activities.
Paul, Baron Stoffels is a Belgian MD, who studied medicine at the University of Hasselt and the University of Antwerp (UA). In addition he studied Infectious Diseases and Tropical Medicine at the Prince Leopold Institute of Tropical Medicine in Antwerp, Belgium. He is Chief Scientific Officier, Worldwide Chairman of Janssen pharmaceuticals and he is a member of the Johnson & Johnson Executive Committee.
Dr. Rudi Pauwels is a Belgian pharmacologist and biotech entrepreneur.
Luc Jacques Leon Cesar, Baron Bertrand is a Belgian businessman. He is the CEO of Ackermans & van Haaren, a company active in construction, dredging, and environmental services, human resources services, financial services, and private equity. The company is headquartered in Antwerp, Belgium.
Didier R.G.G. de Chaffoy de Courcelles is a Belgian scientist and businessman. He was senior vice president of Drug Discovery Europe, and Johnson & Johnson Pharmaceutical Research & Development (J&JPRD), a division of Janssen Pharmaceutica, until 2008 when he left the company.
Ajit, Baron Shetty is a Belgian businessman. He was chairman of the board of directors of Janssen Pharmaceutica, a pharmaceutical company and subsidiary of Johnson & Johnson, with its headquarters in Beerse, Belgium, until February 2012, when he retired. Shetty also served as a member of the Corporate Center Group Operating Committee and vice president, Enterprise Supply Chain for Johnson & Johnson of New Brunswick, New Jersey, in the United States.
Dr. Jan Constant Janssen was a Belgian physician and businessman. He was the third child of Adriaan Victor Janssen (1854–1942) and Anna Catharina Eelen (1855–1929). He went to high school in Hoogstraten and studied medicine at the Catholic University of Leuven and the University of Ghent. On 16 April 1925, he married Margriet Fleerackers, together they had four children. Their oldest son, Paul Janssen, would become one of the most successful scientists in pharmaceutics.
Baron Robert "Bob" Stouthuysen is a Belgian businessman. He is honorary president of the Vlaams Economisch Verbond and of Janssen Pharmaceutica. He lives in Turnhout in the Campine region of Flanders.
Baron Frans Van den Bergh was a Belgian businessman, who founded the cigar factory Alto in Turnhout, Belgium, and who would become one of the leading managers of Janssen Pharmaceutica. In addition to his success with Alto, he was by the marriage of his daughter Lea related to Margriet Fleerackers, the mother of Dr. Paul Janssen. For these reasons, he was asked by the parents of Dr. Paul Janssen, Constant Janssen and Margriet Fleerackers, to help them manage the growing family business with its five branches.
Erik Tambuyzer is a Belgian bio-engineer and businessman. He is Chairman of the Board of the Flemish Center for Medical Innovation (CMI).
Jan A. J. Schuurkes is a Dutch biologist and gastrointestinal researcher.
Koen Andries is a Belgian Janssen Pharmaceutica scientist and professor at the University of Antwerp. In 2005 he and his team published a discovery about a new di-Aryl-Quinoline-based drug (R207910), now called bedaquiline, which promises a shorter and simpler treatment for drug resistant Tuberculosis (TB).
Jean-Pierre, Baron de Bandt is a Belgian lawyer and former the President of the Coudenberg group, a Belgian federalist think tank.
Ann Van Gysel is a Belgian scientist and businesswoman. In 2011 she started Turnstone Communications, offering communications and business development services to biotech and pharma industry. She teaches science communications at the University of Antwerp (UA) and Gent (UGent) and is a director to the board of the Institute of Tropical Medicine Antwerp (ITG).
Paul Appermont is a Belgian businessman. Together with Joos Horsten, he laid the foundation of Xi'an Janssen Pharmaceutical. Appermont is a member of the board of EuropaBio.
Anil Koul is a scientist and former Director of the CSIR-Institute of Microbial Technology (IMTECH), a premier biomedical and biotechnology research institution under Council of Scientific and Industrial Research (CSIR) under Ministry of Science and Technology, Govt. of India.